Top

The Journal of Headache and Pain

Published in:

Open Access 01-12-2018 | Review article

Polygenic risk score: use in migraine research

Authors: Mona Ameri Chalmer, Ann-Louise Esserlind, Jes Olesen, Thomas Folkmann Hansen

Published in: The Journal of Headache and Pain | Issue 1/2018

Abstract

Background

The latest Genome-Wide Association Study identified 38 genetic variants associated with migraine. In this type of studies the significance level is very difficult to achieve (5 × 10^− 8) due to multiple testing. Thus, the identified variants only explain a small fraction of the genetic risk. It is expected that hundreds of thousands of variants also confer an increased risk but do not reach significance levels. One way to capture this information is by constructing a Polygenic Risk Score. Polygenic Risk Score has been widely used with success in genetics studies within neuropsychiatric disorders. The use of polygenic scores is highly relevant as data from a large migraine Genome-Wide Association Study are now available, which will form an excellent basis for Polygenic Risk Score in migraine studies.

Results

Polygenic Risk Score has been used in studies of neuropsychiatric disorders to assess prediction of disease status in case-control studies, shared genetic correlation between co-morbid diseases, and shared genetic correlation between a disease and specific endophenotypes.

Conclusion

Polygenic Risk Score provides an opportunity to investigate the shared genetic risk between known and previously unestablished co-morbidities in migraine research, and may lead to better and personalized treatment of migraine if used as a clinical assistant when identifying responders to specific drugs. Polygenic Risk Score can be used to analyze the genetic relationship between different headache types and migraine endophenotypes. Finally, Polygenic Risk Score can be used to assess pharmacogenetic effects, and perhaps help to predict efficacy of the Calcitonin Gene-Related Peptide monoclonal antibodies that soon become available as migraine treatment.

Keywords

Migraine genetics; Genome-Wide Association Studies; Polygenic Risk Score; pleiotropy; endophenotype.

Stewart WF, Shechter A, Lipton RB (1994) Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration. Neurology 44:S24–S39.CrossRefPubMed

Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. BMJ 311:541–544.CrossRefPubMedPubMedCentral

Mulder EJ, Van Baal C, Gaist D et al (2003) Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 6:422–431. https://doi.org/10.1375/136905203770326420.CrossRefPubMed

Russell MB, Iselius L, Olesen J (1995) Inheritance of migraine investigated by complex segregation analysis. Hum Genet 96:726–730.CrossRefPubMed

Bush WS, Moore JH (2012) Chapter 11: genome-wide association studies. PLoS Comput Biol 8. https://doi.org/10.1371/journal.pcbi.1002822.

Gormley P, Anttila V, Winsvold BS et al (2016) Corrigendum: meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 48:1296–1296. https://doi.org/10.1038/ng1016-1296c.CrossRefPubMed

Dudbridge F (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet 9:e1003348. https://doi.org/10.1371/journal.pgen.1003348.CrossRefPubMedPubMedCentral

Wray NR, Lee SH, Mehta D et al (2014) Research review: polygenic methods and their application to psychiatric traits. J Child Psychol Psychiatry 55:1068–1087. https://doi.org/10.1111/jcpp.12295.CrossRefPubMed

Purcell SM, Wray NR, Stone JL et al (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460:748–752. https://doi.org/10.1038/nature08185.PubMed

10.

Palla L, Dudbridge F (2015) A fast method that uses polygenic scores to estimate the variance explained by genome-wide marker panels and the proportion of variants affecting a trait. Am J Hum Genet 97:250–259. https://doi.org/10.1016/j.ajhg.2015.06.005.CrossRefPubMedPubMedCentral

11.

Dudbridge F, Pashayan N, Yang J (2018) Predictive accuracy of combined genetic and environmental risk scores. Genet Epidemiol 42:4–19. https://doi.org/10.1002/gepi.22092.CrossRefPubMed

12.

Sivakumaran S, Agakov F, Theodoratou E et al (2011) Abundant pleiotropy in human complex diseases and traits. Am J Hum Genet 89:607–618. https://doi.org/10.1016/j.ajhg.2011.10.004.CrossRefPubMedPubMedCentral

13.

Stower H (2012) Human genetics: pleiotropic mutations. Nat Rev Genet 13:5. https://doi.org/10.1038/nrg3132.CrossRef

14.

Fuller Torrey E (1999) Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr Res 39:101–106. https://doi.org/10.1016/S0920-9964(99)00107-3.CrossRef

15.

(2013) Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381:1371–9. doi: https://doi.org/10.1016/S0140-6736(12)62129-1.

16.

Power RA, Steinberg S, Bjornsdottir G et al (2015) Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci 18:953–955. https://doi.org/10.1038/nn.4040.CrossRefPubMed

17.

Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645. https://doi.org/10.1176/appi.ajp.160.4.636.CrossRefPubMed

18.

Reitz C, Mayeux R (2009) Endophenotypes in normal brain morphology and Alzheimer’s disease: a review. Neuroscience 164:174–190. https://doi.org/10.1016/j.neuroscience.2009.04.006.CrossRefPubMedPubMedCentral

19.

Stanke F, Hedtfeld S, Becker T, Tümmler B (2011) An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion. BMC Med Genet 12:62. https://doi.org/10.1186/1471-2350-12-62.CrossRefPubMedPubMedCentral

20.

Kauppi K, Westlye LT, Tesli M et al (2014) Polygenic risk for schizophrenia associated with working memory-related prefrontal brain activation in patients with schizophrenia and healthy controls. Schizophr Bull. https://doi.org/10.1093/schbul/sbu152.

21.

Whalley HC, Hall L, Romaniuk L et al (2015) Impact of cross-disorder polygenic risk on frontal brain activation with specific effect of schizophrenia risk. Schizophr Res 161:484–489. https://doi.org/10.1016/j.schres.2014.10.046.CrossRefPubMedPubMedCentral

22.

Whalley HC, Papmeyer M, Sprooten E et al (2012) The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI. Transl Psychiatry 2:e130. https://doi.org/10.1038/tp.2012.60.CrossRefPubMedPubMedCentral

23.

Hamshere ML, O’Donovan MC, Jones IR et al (2011) Polygenic dissection of the bipolar phenotype. Br J Psychiatry 198:284–288. https://doi.org/10.1192/bjp.bp.110.087866.CrossRefPubMedPubMedCentral

24.

(2013) Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies. Am J Psychiatry 170:207–17. doi: https://doi.org/10.1176/appi.ajp.2012.12020237.

25.

Tansey KE, Guipponi M, Domenici E et al (2014) Genetic susceptibility for bipolar disorder and response to antidepressants in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 165B:77–83. https://doi.org/10.1002/ajmg.b.32210.CrossRefPubMed

26.

Ligthart L, Hottenga J-J, Lewis CM et al (2013) Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders. Hum Genet 133:173–186. https://doi.org/10.1007/s00439-013-1370-8.CrossRefPubMedPubMedCentral

27.

Malik R, Freilinger T, Winsvold BS et al (2015) Shared genetic basis for migraine and ischemic stroke: a genome-wide analysis of common variants. Neurology. https://doi.org/10.1212/WNL.0000000000001606.

28.

Anttila V, Finucane H, Walters R, et al (2016) Analysis of Shared Heritability in Common Disorders of the Brain multiple distinct brain phenotypes ( 12–14 ). Recently, genome-wide association studies ( GWAS ). doi: https://doi.org/10.1101/048991. doi: Anttila, V., Finucane, H., Walters, R., Bras, J., Duncan, L., Lee, P.H., Turley, P., Consortium, I., 2016. Analysis of Shared Heritability in Common Disorders of the Brain multiple distinct brain phenotypes ( 12–14 ). Recently, genome-wide association studies ( GWAS ). doi:https://doi.org/10.1101/048991.

29.

Le H, Tfelt-Hansen P, Russell MB et al (2011) Co-morbidity of migraine with somatic disease in a large population-based study. Cephalalgia 31:43–64. https://doi.org/10.1177/0333102410373159.CrossRefPubMed

30.

Hagen K, Bjøro T, Zwart JA et al (2001) Low headache prevalence amongst women with high TSH values. Eur J Neurol 8:693–699.CrossRefPubMed

31.

Hagen K, Einarsen C, Zwart J-A et al (2002) The co-occurrence of headache and musculoskeletal symptoms amongst 51 050 adults in Norway. Eur J Neurol 9:527–533.CrossRefPubMed

32.

Vij B, Whipple MO, Tepper SJ et al (2015) Frequency of migraine headaches in patients with fibromyalgia. Headache. https://doi.org/10.1111/head.12590.

33.

Dosi C, Figura M, Ferri R, Bruni O (2015) Sleep and headache. Semin Pediatr Neurol 22:105–112. https://doi.org/10.1016/j.spen.2015.04.005.CrossRefPubMed

34.

Ferrero S, Pretta S, Bertoldi S et al (2004) Increased frequency of migraine among women with endometriosis. Hum Reprod 19:2927–2932. https://doi.org/10.1093/humrep/deh537.CrossRefPubMed

35.

Tietjen GE, Conway A, Utley C et al (2006) Migraine is associated with menorrhagia and endometriosis. Headache 46:422–428. https://doi.org/10.1111/j.1526-4610.2006.00290.x.CrossRefPubMed

36.

Nyholt DR, Gillespie NG, Merikangas KR et al (2009) Common genetic influences underlie comorbidity of migraine and endometriosis. Genet Epidemiol 33:105–113. https://doi.org/10.1002/gepi.20361.CrossRefPubMedPubMedCentral

37.

Huber D, Henrich G (2003) Personality traits and stress sensitivity in migraine patients. Behav Med 29:4–13.CrossRefPubMed

38.

Pompili M, Di Cosimo D, Innamorati M et al (2009) Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk. J Headache Pain 10:283–290. https://doi.org/10.1007/s10194-009-0134-2.CrossRefPubMedPubMedCentral

39.

Schurks M, Rist PM, Kurth T (2010) Sex hormone receptor gene polymorphisms and migraine: a systematic review and meta-analysis. Cephalalgia 30:1306–1328. https://doi.org/10.1177/0333102410364155.CrossRefPubMedPubMedCentral

40.

Goadsby PJ, Charbit AR, Andreou AP et al (2009) Neurobiology of migraine. Neuroscience 161:327–341. https://doi.org/10.1016/j.neuroscience.2009.03.019.CrossRefPubMed

41.

Russell MB, Levi N, Kaprio J (2007) Genetics of tension-type headache: a population based twin study. Am J Med Genet Part B Neuropsychiatr Genet 144:982–986. https://doi.org/10.1002/ajmg.b.30497.CrossRef

42.

Christensen AF, Esserlind A-L, Werge T et al (2016) The influence of genetic constitution on migraine drug responses. Cephalalgia 36:624–639. https://doi.org/10.1177/0333102415610874.CrossRefPubMed

43.

Diener H-C, Limmroth V (2001) Advances in pharmacological treatment of migraine. Expert Opin Investig Drugs 10:1831–1845. https://doi.org/10.1517/13543784.10.10.1831.CrossRefPubMed

44.

(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211. doi: https://doi.org/10.1177/0333102417738202.

45.

GW B (1984) Intracranial arteriovenous malformation and migraine. Cephalalgia.

46.

Pavlakis SG, Phillips PC, DiMauro S et al (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488. https://doi.org/10.1002/ana.410160409.CrossRefPubMed

47.

Vérin M, Rolland Y, Landgraf F et al (1995) New phenotype of the cerebral autosomal dominant arteriopathy mapped to chromosome 19: migraine as the prominent clinical feature. J Neurol Neurosurg Psychiatry 59:579–585. https://doi.org/10.1136/jnnp.59.6.579.CrossRefPubMedPubMedCentral

48.

Chabriat H, Vahedi K, Bousser MG et al (1995) Clinical spectrum of CADASIL: a study of 7 families. Lancet 346:934–939. https://doi.org/10.1016/S0140-6736(95)91557-5.CrossRefPubMed

49.

Foley SF, Tansey KE, Caseras X et al (2017) Multimodal brain imaging reveals structural differences in Alzheimer’s disease polygenic risk carriers: a study in healthy young adults. Biol Psychiatry 81:154–161. https://doi.org/10.1016/j.biopsych.2016.02.033.CrossRefPubMedPubMedCentral

50.

Rodriguez-Acevedo AJ, Ferreira MA, Benton MC et al (2015) Common polygenic variation contributes to risk of migraine in the Norfolk Island population. Hum Genet 134:1079–1087. https://doi.org/10.1007/s00439-015-1587-9.CrossRefPubMed

51.

Ruderfer DM, Kirov G, Chambert K, et al (2011) A family-based study of common polygenic variation and risk of schizophrenia. Mol Psychiatry 16:887–8. doi: https://doi.org/10.1038/mp.2011.34.

52.

Chang S-C, Glymour MM, Walter S et al (2014) Genome-wide polygenic scoring for a 14-year long-term average depression phenotype. Brain Behav 4:298–311. https://doi.org/10.1002/brb3.205.CrossRefPubMedPubMedCentral

53.

Cornelis MC, Monda KL, Yu K et al (2011) Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption. PLoS Genet 7:e1002033. https://doi.org/10.1371/journal.pgen.1002033.CrossRefPubMedPubMedCentral

54.

Goes FS, Hamshere ML, Seifuddin F et al (2012) Genome-wide association of mood-incongruent psychotic bipolar disorder. Transl Psychiatry 2:e180. https://doi.org/10.1038/tp.2012.106.CrossRefPubMedPubMedCentral

55.

Demirkan A, Penninx BWJH, Hek K et al (2011) Genetic risk profiles for depression and anxiety in adult and elderly cohorts. Mol Psychiatry 16:773–783. https://doi.org/10.1038/mp.2010.65.CrossRefPubMed

56.

Peyrot WJ, Milaneschi Y, Abdellaoui A et al (2014) Effect of polygenic risk scores on depression in childhood trauma. Br J Psychiatry 205:113–119. https://doi.org/10.1192/bjp.bp.113.143081.CrossRefPubMedPubMedCentral

57.

(2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43:977–83. doi: https://doi.org/10.1038/ng.943.

58.

Ruderfer DM, Fanous AH, Ripke S et al (2014) Polygenic dissection of diagnosis and clinical dimensions of bipolar disorder and schizophrenia. Mol Psychiatry 19:1017–1024. https://doi.org/10.1038/mp.2013.138.CrossRefPubMed

59.

Ikeda M, Okahisa Y, Aleksic B et al (2013) Evidence for shared genetic risk between methamphetamine-induced psychosis and schizophrenia. Neuropsychopharmacology 38:1864–1870. https://doi.org/10.1038/npp.2013.94.CrossRefPubMedPubMedCentral

60.

Solovieff N, Roberts AL, Ratanatharathorn A et al (2014) Genetic association analysis of 300 genes identifies a risk haplotype in SLC18A2 for post-traumatic stress disorder in two independent samples. Neuropsychopharmacology 39:1872–1879. https://doi.org/10.1038/npp.2014.34.CrossRefPubMedPubMedCentral

61.

Byrne EM, Carrillo-Roa T, Penninx BWJH et al (2014) Applying polygenic risk scores to postpartum depression. Arch Womens Ment Health 17:519–528. https://doi.org/10.1007/s00737-014-0428-5.CrossRefPubMedPubMedCentral

62.

Ferentinos P, Rivera M, Ising M et al (2014) Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution. J Affect Disord 155:81–89. https://doi.org/10.1016/j.jad.2013.10.027.CrossRefPubMed

63.

Ripke S, Wray NR, Lewis CM et al (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18:497–511. https://doi.org/10.1038/mp.2012.21.CrossRefPubMed

64.

Wiste A, Robinson EB, Milaneschi Y et al (2014) Bipolar polygenic loading and bipolar spectrum features in major depressive disorder. Bipolar Disord 16:608–616. https://doi.org/10.1111/bdi.12201.CrossRefPubMedPubMedCentral

65.

Musliner KL, Seifuddin F, Judy JA et al (2014) Polygenic risk, stressful life events and depressive symptoms in older adults: a polygenic score analysis. Psychol Med:1–12. https://doi.org/10.1017/S0033291714002839.

66.

Derks EM, Vorstman JAS, Ripke S et al (2012) Investigation of the genetic association between quantitative measures of psychosis and schizophrenia: a polygenic risk score analysis. PLoS One 7:e37852. https://doi.org/10.1371/journal.pone.0037852.CrossRefPubMedPubMedCentral

67.

Mullins N, Perroud N, Uher R et al (2014) Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. Am J Med Genet B Neuropsychiatr Genet 165B:428–437. https://doi.org/10.1002/ajmg.b.32247.CrossRefPubMed

68.

Nievergelt CM, Maihofer AX, Mustapic M et al (2015) Genomic predictors of combat stress vulnerability and resilience in U.S. marines: a genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology 51:459–471. https://doi.org/10.1016/j.psyneuen.2014.10.017.CrossRefPubMed

69.

Middeldorp CM, de Moor MHM, McGrath LM et al (2011) The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data. Transl. Psychiatry 1:e50. https://doi.org/10.1038/tp.2011.45.

70.

Terwisscha van Scheltinga AF, Bakker SC, van Haren NEM et al (2013) Genetic schizophrenia risk variants jointly modulate total brain and white matter volume. Biol Psychiatry 73:525–531. https://doi.org/10.1016/j.biopsych.2012.08.017.CrossRefPubMed

71.

Whalley HC, Sprooten E, Hackett S et al (2013) Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Biol Psychiatry 74:280–286. https://doi.org/10.1016/j.biopsych.2013.01.027.CrossRefPubMedPubMedCentral

72.

Walton E, Geisler D, Lee PH et al (2014) Prefrontal inefficiency is associated with polygenic risk for schizophrenia. Schizophr Bull 40:1263–1271. https://doi.org/10.1093/schbul/sbt174.CrossRefPubMed

73.

Hall M-H, Chen C-Y, Cohen BM et al (2015) Genomewide association analyses of electrophysiological endophenotypes for schizophrenia and psychotic bipolar disorders: a preliminary report. Am J Med Genet B Neuropsychiatr Genet 168:151–161. https://doi.org/10.1002/ajmg.b.32298.CrossRef

74.

Holmes AJ, Lee PH, Hollinshead MO et al (2012) Individual differences in amygdala-medial prefrontal anatomy link negative affect, impaired social functioning, and polygenic depression risk. J Neurosci 32:18087–18100. https://doi.org/10.1523/JNEUROSCI.2531-12.2012.CrossRefPubMedPubMedCentral

Title: Polygenic risk score: use in migraine research
Authors: Mona Ameri Chalmer
Ann-Louise Esserlind
Jes Olesen
Thomas Folkmann Hansen
Publication date: 01-12-2018
Publisher: Springer Milan
Published in: The Journal of Headache and Pain / Issue 1/2018
Print ISSN: 1129-2369
Electronic ISSN: 1129-2377
DOI: https://doi.org/10.1186/s10194-018-0856-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Polygenic risk score: use in migraine research

Abstract

Background

Results

Conclusion

Keywords

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusion

Keywords

Please log in to get access to this content

Other articles of this Issue 1/2018

Effectiveness of transcutaneous electrical nerve stimulation for the treatment of migraine: a meta-analysis of randomized controlled trials

Polarity-specific modulation of pain processing by transcranial direct current stimulation – a blinded longitudinal fMRI study

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial

Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation

Pre-treatment with sumatriptan for cilostazol induced headache in healthy volunteers